Early Stomach Adenocarcinoma Tissue Array, 75 Cases. Tumor And Matched NAT*.|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:173317

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Early Stomach Adenocarcinoma Tissue Array, 75 Cases. Tumor And Matched NAT*.)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2024年05月17日 00時01分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Early stomach adenocarcinoma tissue array, 75 cases. Tumor and matched NAT*.
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0

[在庫・価格 :2024年05月17日 00時01分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Early stomach adenocarcinoma tissue array, 75 cases. Tumor and matched NAT*.

文献数: 0

目次に戻る

ヒト組織アレイの特長

Description: 2 cores/case. Clinical stage Ⅰ. 29 cases of T1N0M0, 5 cases of T1N1M0, 41 cases of T2N0M0.
Cores: 150
Cases: 75
Layout: 16 cols × 10 rows
Core Diameter: 1.5 mm
Thickness: 4 µm
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 40 Stomach Adenocarcinoma G3 IA T1aN0M0 Tumor
A2 2 M 40 Stomach NAT NAT
A3 3 M 59 Stomach Adenocarcinoma G2-G3 IA T1aN0M0 Tumor
A4 4 M 59 Stomach NAT NAT
A5 5 F adult Stomach Adenocarcinoma G3 IA T1aN0M0 Tumor
A6 6 F adult Stomach NAT NAT
A7 7 M 63 Stomach Adenocarcinoma G3 IA T1aN0M0 Tumor
A8 8 M 63 Stomach NAT NAT
A9 9 M 67 Stomach Adenocarcinoma G1 IA T1aN0M0 Tumor
A10 10 M 67 Stomach NAT NAT
A11 11 F 57 Stomach Adenocarcinoma G2 IA T1aN0M0 Tumor
A12 12 F 57 Stomach NAT NAT
A13 13 F 45 Stomach Adenocarcinoma G1-G2 IA T1aN0M0 Tumor
A14 14 F 45 Stomach NAT NAT
A15 15 M 44 Stomach Adenocarcinoma G2-G3 IA T1aN0M0 Tumor
A16 16 M 44 Stomach NAT NAT
B1 17 F 74 Stomach Adenocarcinoma G3 IA T1bN0M0 Tumor
B2 18 F 74 Stomach NAT NAT
B3 19 F 76 Stomach Adenocarcinoma G2 IA T1bN0M0 Tumor
B4 20 F 76 Stomach NAT NAT
B5 21 F 80 Stomach Adenocarcinoma G3 IA T1bN0M0 Tumor
B6 22 F 80 Stomach NAT NAT
B7 23 M 73 Stomach Adenocarcinoma G2-G3 IA T1bN0M0 Tumor
B8 24 M 73 Stomach NAT NAT
B9 25 M 63 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
B10 26 M 63 Stomach NAT NAT
B11 27 M 77 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
B12 28 M 77 Stomach NAT NAT
B13 29 M 73 Stomach Adenocarcinoma G1-G3 IA T1bN0M0 Tumor
B14 30 M 73 Stomach NAT NAT
B15 31 M 75 Stomach Adenocarcinoma G3 IA T1bN0M0 Tumor
B16 32 M 75 Stomach NAT NAT
C1 33 F 26 Stomach Adenocarcinoma G3 IA T1bN0M0 Tumor
C2 34 F 26 Stomach NAT NAT
C3 35 M 58 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
C4 36 M 58 Stomach NAT NAT
C5 37 F 55 Stomach Adenocarcinoma G2-G3 IA T1bN0M0 Tumor
C6 38 F 55 Stomach NAT NAT
C7 39 F 61 Stomach Adenocarcinoma G2-G3 IA T1bN0M0 Tumor
C8 40 F 61 Stomach NAT NAT
C9 41 M 70 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
C10 42 M 70 Stomach NAT NAT
C11 43 M 49 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
C12 44 M 49 Stomach NAT NAT
C13 45 M 49 Stomach Adenocarcinoma G1 IA T1bN0M0 Tumor
C14 46 M 49 Stomach NAT NAT
C15 47 M 77 Stomach Adenocarcinoma G2 IA T1bN0M0 Tumor
C16 48 M 77 Stomach NAT NAT
D1 49 F 45 Stomach Adenocarcinoma G3 IA T1bN0M0 Tumor
D2 50 F 45 Stomach NAT NAT
D3 51 —— 45 Stomach Adenocarcinoma G1-G2 IA T1N0M0 Tumor
D4 52 —— 45 Stomach NAT NAT
D5 53 F 59 Stomach Adenocarcinoma G3 IA T1N0M0 Tumor
D6 54 F 59 Stomach NAT NAT
D7 55 M 50 Stomach Adenocarcinoma G2 IA T1N0M0 Tumor
D8 56 M 50 Stomach NAT NAT
D9 57 F 79 Stomach Adenocarcinoma G2 IA T1N0M0 Tumor
D10 58 F 79 Stomach NAT NAT
D11 59 M 60 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
D12 60 M 60 Stomach NAT NAT
D13 61 F 57 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
D14 62 F 57 Stomach NAT NAT
D15 63 M 72 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
D16 64 M 72 Stomach NAT NAT
E1 65 F 68 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
E2 66 F 68 Stomach NAT NAT
E3 67 F 66 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
E4 68 F 66 Stomach NAT NAT
E5 69 M 66 Stomach Adenocarcinoma G1 IB T2N0M0 Tumor
E6 70 M 66 Stomach NAT NAT
E7 71 M 51 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
E8 72 M 51 Stomach NAT NAT
E9 73 M 72 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
E10 74 M 72 Stomach NAT NAT
E11 75 F 60 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
E12 76 F 60 Stomach NAT NAT
E13 77 M 68 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
E14 78 M 68 Stomach NAT NAT
E15 79 M 55 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
E16 80 M 55 Stomach NAT NAT
F1 81 M 73 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
F2 82 M 73 Stomach NAT NAT
F3 83 F 52 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
F4 84 F 52 Stomach NAT NAT
F5 85 M 64 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
F6 86 M 64 Stomach NAT NAT
F7 87 M 53 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
F8 88 M 53 Stomach NAT NAT
F9 89 M 65 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
F10 90 M 65 Stomach NAT NAT
F11 91 F 62 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
F12 92 F 62 Stomach NAT NAT
F13 93 M 52 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
F14 94 M 52 Stomach NAT NAT
F15 95 M 65 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
F16 96 M 65 Stomach NAT NAT
G1 97 M 67 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
G2 98 M 67 Stomach NAT NAT
G3 99 M 68 Stomach Adenocarcinoma G1 IB T2N0M0 Tumor
G4 100 M 68 Stomach NAT NAT
G5 101 M 69 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
G6 102 M 69 Stomach NAT NAT
G7 103 F 51 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
G8 104 F 51 Stomach NAT NAT
G9 105 M 73 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
G10 106 M 73 Stomach NAT NAT
G11 107 M 50 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
G12 108 M 50 Stomach NAT NAT
G13 109 M 76 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
G14 110 M 76 Stomach NAT NAT
G15 111 M 65 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
G16 112 M 65 Stomach NAT NAT
H1 113 M 59 Stomach Adenocarcinoma G3-G4 IB T2N0M0 Tumor
H2 114 M 59 Stomach NAT NAT
H3 115 F 57 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
H4 116 F 57 Stomach NAT NAT
H5 117 F 59 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
H6 118 F 59 Stomach NAT NAT
H7 119 M 66 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
H8 120 M 66 Stomach NAT NAT
H9 121 M 49 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
H10 122 M 49 Stomach NAT NAT
H11 123 F 72 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
H12 124 F 72 Stomach NAT NAT
H13 125 M 62 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
H14 126 M 62 Stomach NAT NAT
H15 127 M 47 Stomach Adenocarcinoma G1-G2 IB T2N0M0 Tumor
H16 128 M 47 Stomach NAT NAT
I1 129 M 42 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
I2 130 M 42 Stomach NAT NAT
I3 131 M 62 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
I4 132 M 62 Stomach NAT NAT
I5 133 F 64 Stomach Adenocarcinoma G3 IB T2N0M0 Tumor
I6 134 F 64 Stomach NAT NAT
I7 135 M 72 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
I8 136 M 72 Stomach NAT NAT
I9 137 F 73 Stomach Adenocarcinoma G2 IB T2N0M0 Tumor
I10 138 F 73 Stomach NAT NAT
I11 139 F 75 Stomach Adenocarcinoma G2-G3 IB T2N0M0 Tumor
I12 140 F 75 Stomach NAT NAT
I13 141 F 30 Stomach Adenocarcinoma G3 IB T1aN1M0 Tumor
I14 142 F 30 Stomach NAT NAT
I15 143 M 70 Stomach Adenocarcinoma G3 IB T1bN1M0 Tumor
I16 144 M 70 Stomach NAT NAT
J1 145 F 81 Stomach Adenocarcinoma G3 IB T1bN1M0 Tumor
J2 146 F 81 Stomach NAT NAT
J3 147 F 50 Stomach Adenocarcinoma G2-G3 IB T1bN1M0 Tumor
J4 148 F 50 Stomach NAT NAT
J5 149 F 76 Stomach Adenocarcinoma G3 IB T1N1M0 Tumor
J6 150 F 76 Stomach NAT NAT

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。